Moberg Pharma EBITDA vs. Price To Book
| MOB Stock | SEK 15.48 0.03 0.19% |
For Moberg Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Moberg Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Moberg Pharma AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Moberg Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Moberg Pharma AB over time as well as its relative position and ranking within its peers.
Moberg |
Moberg Pharma AB Price To Book vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Moberg Pharma's current stock value. Our valuation model uses many indicators to compare Moberg Pharma value to that of its competitors to determine the firm's financial worth. Moberg Pharma AB is considered to be number one stock in ebitda category among its peers. It also is considered to be number one stock in price to book category among its peers . The ratio of EBITDA to Price To Book for Moberg Pharma AB is about 15,484,412 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Moberg Pharma's earnings, one of the primary drivers of an investment's value.Moberg Price To Book vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Moberg Pharma |
| = | 6.46 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Moberg Pharma |
| = | 0.42 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Moberg Price To Book Comparison
Moberg Pharma is currently under evaluation in price to book category among its peers.
Moberg Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Moberg Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Moberg Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Moberg Pharma's change in net profit over the period of time. It can combine multiple indicators of Moberg Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. Moberg Pharma operates under Drug ManufacturersSpecialty Generic classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.
Moberg Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Moberg Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Moberg Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Moberg Pharma's important profitability drivers and their relationship over time.
Use Moberg Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Moberg Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moberg Pharma will appreciate offsetting losses from the drop in the long position's value.Moberg Pharma Pair Trading
Moberg Pharma AB Pair Trading Analysis
The ability to find closely correlated positions to Moberg Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Moberg Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Moberg Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Moberg Pharma AB to buy it.
The correlation of Moberg Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Moberg Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Moberg Pharma AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Moberg Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Moberg Pharma position
In addition to having Moberg Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corona Opportunity Thematic Idea Now
Corona Opportunity
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Moberg Stock Analysis
When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.